Abstract
Sevoflurane, a common used inhaled anaesthetic, induces neuronal apoptosis in preclinical studies and correlates with functional neurological impairment. We investigated whether FTY720, a known sphingosine-1 phosphate (S1P) receptor agonist, could exert neuroprotective effect against sevoflurane-induced neurotoxicity. Neuroprotective effect of FTY720 was evaluated in vitro in hippocampal neuronal cells from neonatal rats and in vivo in rat pups. In vitro cell apoptosis was determined by flow cytometry after exposure to 3 % sevoflurane for different period of time, or after 6-h exposure to sevoflurane with the presence of FTY720, SEW2871 (selective S1P1 receptor agonist) or combination of FTY720 and VPC23019 (S1P antagonist). Western blot analysis was performed with hippocampal tissue from rat pups exposed to 3 % sevoflurane for 6 h with or without pre-treatment with FTY720 injection. Neurological function tests were also performed with rat pups exposed to 3 % sevoflurane for 6 h with or without pre-treatment with FTY720 injection. FTY720, at nanomolar concentration, significantly prevents sevoflurane-induced neuronal apoptosis. SEW2871 showed similar neuroprotective effect to FTY720, whereas VPC23019 abrogated the neuroprotective effect of FTY720 when given together. Western blots results demonstrated that FTY710 significantly preserved the level of phosphorylated ERK1/2, Bcl-2 and Bax. Although anaesthetic treatment did not affect general health and emotional status, sevoflurane-induced cognitive impairment in rat models. Administration of FTY720 at 1 mg/kg significantly attenuated sevoflurane-induced neurocognitive impairment. Although further studies are needed to evaluate the feasibility of clinical usage of FTY720 as neuroprotective agent, the study provides preclinical experimental evidence for the efficacy of FTY720 against sevoflurane-induced developmental neurotoxicity.
Similar content being viewed by others
References
Wilder, R. T., Flick, R. P., Sprung, J., Katusic, S. K., Barbaresi, W. J., Mickelson, C., et al. (2009). Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology, 110(4), 796–804.
Kalkman, C. J., Peelen, L., Moons, K. G., Veenhuizen, M., Bruens, M., Sinnema, G., et al. (2009). Behavior and development in children and age at the time of first anesthetic exposure. Anesthesiology, 110(4), 805–812.
Brambrink, A. M., Evers, A. S., Avidan, M. S., Farber, N. B., Smith, D. J., Zhang, X., et al. (2010). Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain. Anesthesiology, 112(4), 834–841.
Edsall, L. C., Pirianov, G. G., & Spiegel, S. (1997). Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation. Journal of Neuroscience, 17(18), 6952–6960.
Shinpo, K., Kikuchi, S., Moriwaka, F., & Tashiro, K. (1999). Protective effects of the TNF-ceramide pathway against glutamate neurotoxicity on cultured mesencephalic neurons. Brain Research, 819(1–2), 170–173.
Edsall, L. C., Cuvillier, O., Twitty, S., Spiegel, S., & Milstien, S. (2001). Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells. Journal of Neurochemistry, 76(5), 1573–1584.
Meng, H., Yuan, Y., & Lee, V. M. (2011). Loss of sphingosine kinase 1/S1P signaling impairs cell growth and survival of neurons and progenitor cells in the developing sensory ganglia. PLoS One, 6(11), e27150.
Czech, B., Pfeilschifter, W., Mazaheri-Omrani, N., Strobel, M. A., Kahles, T., Neumann-Haefelin, T., et al. (2009). The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia. Biochemical and Biophysical Research Communications, 389(2), 251–256.
Hasegawa, Y., Suzuki, H., Sozen, T., Rolland, W., & Zhang, J. H. (2010). Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke, 41(2), 368–374.
Rolland, II, W. B, Manaenko, A., Lekic, T., Hasegawa, Y., Ostrowski, R., Tang, J., et al. (2011). FTY720 is neuroprotective and improves functional outcomes after intracerebral hemorrhage in mice. Acta Neurochirurgica. Supplementum, 111, 213–217.
Wei, Y., Yemisci, M., Kim, H. H., Yung, L. M., Shin, H. K., Hwang, S. K., et al. (2011). Fingolimod provides long-term protection in rodent models of cerebral ischemia. Annals of Neurology, 69(1), 119–129.
Norimatsu, Y., Ohmori, T., Kimura, A., Madoiwa, S., Mimuro, J., Seichi, A., et al. (2012). FTY720 improves functional recovery after spinal cord injury by primarily nonimmunomodulatory mechanisms. American Journal of Pathology, 180(4), 1625–1635.
Vincent, A. M., & Maiese, K. (2000). The metabotropic glutamate system promotes neuronal survival through distinct pathways of programmed cell death. Experimental Neurology, 166(1), 65–82.
Lu, Y., Wu, X., Dong, Y., Xu, Z., Zhang, Y., & Xie, Z. (2010). Anesthetic sevoflurane causes neurotoxicity differently in neonatal naive and Alzheimer disease transgenic mice. Anesthesiology, 112(6), 1404–1416.
Sanders, R. D., Xu, J., Shu, Y., Januszewski, A., Halder, S., Fidalgo, A., et al. (2009). Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology, 110(5), 1077–1085.
Wei, H., Kang, B., Wei, W., Liang, G., Meng, Q. C., Li, Y., et al. (2005). Isoflurane and sevoflurane affect cell survival and BCL-2/BAX ratio differently. Brain Research, 1037(1–2), 139–147.
Wakade, C., King, M. D., Laird, M. D., Alleyne, C. H, Jr, & Dhandapani, K. M. (2009). Curcumin attenuates vascular inflammation and cerebral vasospasm after subarachnoid hemorrhage in mice. Antioxidants & Redox Signaling, 11(1), 35–45.
Laird, M. D., Sukumari-Ramesh, S., Swift, A. E., Meiler, S. E., Vender, J. R., & Dhandapani, K. M. (2010). Curcumin attenuates cerebral edema following traumatic brain injury in mice: a possible role for aquaporin-4? Journal of Neurochemistry, 113(3), 637–648.
Biegon, A., Fry, P. A., Paden, C. M., Alexandrovich, A., Tsenter, J., & Shohami, E. (2004). Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: Implications for treatment of neurological and cognitive deficits. Proceedings of the National Academy of Sciences of the United States of America, 101(14), 5117–5122.
Oyama, Y., Chikahisa, L., Kanemaru, K., Nakata, M., Noguchi, S., Nagano, T., et al. (1998). Cytotoxic actions of FTY720, a novel immunosuppressant, on thymocytes and brain neurons dissociated from the rat. Japanese Journal of Pharmacology, 76(4), 377–385.
Foster, C. A., Howard, L. M., Schweitzer, A., Persohn, E., Hiestand, P. C., Balatoni, B., et al. (2007). Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis. Journal of Pharmacology and Experimental Therapeutics, 323(2), 469–475.
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., et al. (2002). The immune modulator FTY720 targets sphingosine 1-phosphate receptors. Journal of Biological Chemistry, 277(24), 21453–21457.
Mullershausen, F., Craveiro, L. M., Shin, Y., Cortes-Cros, M., Bassilana, F., Osinde, M., et al. (2007). Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors. Journal of Neurochemistry, 102(4), 1151–1161.
Osinde, M., Mullershausen, F., & Dev, K. K. (2007). Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors. Neuropharmacology, 52(5), 1210–1218.
Zhang, Y., Dong, Y., Wu, X., Lu, Y., Xu, Z., Knapp, A., et al. (2010). The mitochondrial pathway of anesthetic isoflurane-induced apoptosis. Journal of Biological Chemistry, 285(6), 4025–4037.
Chiba, K. (2005). FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors. Pharmacology & Therapeutics, 108(3), 308–319.
Jevtovic-Todorovic, V., Hartman, R. E., Izumi, Y., Benshoff, N. D., Dikranian, K., Zorumski, C. F., et al. (2003). Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. Journal of Neuroscience, 23(3), 876–882.
Fanselow, M. S. (2000). Contextual fear, gestalt memories, and the hippocampus. Behavioural Brain Research, 110(1–2), 73–81.
Quinn, J. J., Loya, F., Ma, Q. D., & Fanselow, M. S. (2005). Dorsal hippocampus NMDA receptors differentially mediate trace and contextual fear conditioning. Hippocampus, 15(5), 665–674.
Wang, W. Y., Wang, H., Luo, Y., Jia, L. J., Zhao, J. N., Zhang, H. H., et al. (2012). The effects of metabotropic glutamate receptor 7 allosteric agonist N,N′-dibenzhydrylethane-1,2-diamine dihydrochloride on developmental sevoflurane neurotoxicity: role of extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase signaling pathway. Neuroscience, 205, 167–177.
Stessin, A. M., Gursel, D. B., Schwartz, A., Parashar, B., Kulidzhanov, F. G., Sabbas, A. M., et al. (2012). FTY720, sphingosine 1-phosphate receptor modulator, selectively radioprotects hippocampal neural stem cells. Neuroscience Letters, 516(2), 253–258.
Jung, C. G., Kim, H. J., Miron, V. E., Cook, S., Kennedy, T. E., Foster, C. A., et al. (2007). Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells. Glia, 55(16), 1656–1667.
Postma, F. R., Jalink, K., Hengeveld, T., & Moolenaar, W. H. (1996). Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor. EMBO Journal, 15(10), 2388–2392.
Toman, R. E., Payne, S. G., Watterson, K. R., Maceyka, M., Lee, N. H., Milstien, S., et al. (2004). Differential transactivation of sphingosine-1-phosphate receptors modulates NGF-induced neurite extension. Journal of Cell Biology, 166(3), 381–392.
Sato, K., Tomura, H., Igarashi, Y., Ui, M., & Okajima, F. (1997). Exogenous sphingosine 1-phosphate induces neurite retraction possibly through a cell surface receptor in PC12 cells. Biochemical and Biophysical Research Communications, 240(2), 329–334.
Miron, V. E., Schubart, A., & Antel, J. P. (2008). Central nervous system-directed effects of FTY720 (fingolimod). Journal of the Neurological Sciences, 274(1–2), 13–17.
Straiko, M. M., Young, C., Cattano, D., Creeley, C. E., Wang, H., Smith, D. J., et al. (2009). Lithium protects against anesthesia-induced developmental neuroapoptosis. Anesthesiology, 110(4), 862–868.
Wang, Z., Shen, J., Wang, J., Lu, T., Li, C., Zhang, X., et al. (2012). Lithium attenuates bupivacaine-induced neurotoxicity in vitro through phosphatidylinositol-3-kinase/threonine-serine protein kinase B- and extracellular signal-regulated kinase-dependent mechanisms. Neuroscience, 206, 190–200.
Mawhinney, L. J., de Rivero Vaccari, J. P., Alonso, O. F., Jimenez, C. A., Furones, C., Moreno, W. J., et al. (2012). Isoflurane/nitrous oxide anesthesia induces increases in NMDA receptor subunit NR2B protein expression in the aged rat brain. Brain Research, 1431, 23–34.
Fredriksson, A., Ponten, E., Gordh, T., & Eriksson, P. (2007). Neonatal exposure to a combination of N-methyl-d-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits. Anesthesiology, 107(3), 427–436.
Deogracias, R., Klein, C., Matsumoto, T., Yazdani, M., Bibel, M., & Barde, Y. (2008). Expression of brain-derived neurotrophic factor is regulated by FTY720 in cultured neurons. Multiple Sclerosis, 14, S243.
Coelho, R. P., Payne, S. G., Bittman, R., Spiegel, S., & Sato-Bigbee, C. (2007). The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors. Journal of Pharmacology and Experimental Therapeutics, 323(2), 626–635.
Author information
Authors and Affiliations
Corresponding author
Additional information
Hui Zhou and Song Li contributed equally to this study.
Rights and permissions
About this article
Cite this article
Zhou, H., Li, S., Niu, X. et al. Protective Effect of FTY720 Against Sevoflurane-Induced Developmental Neurotoxicity in Rats. Cell Biochem Biophys 67, 591–598 (2013). https://doi.org/10.1007/s12013-013-9546-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-013-9546-3